Results 231 to 240 of about 1,608,385 (286)

Lymphatic Abnormalities in Noonan Syndrome Extend Beyond Clinically Apparent Disease

American Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2211-2223, October 2026.
ABSTRACT Lymphatic disease represents a well‐described manifestation of Noonan syndrome (NS), yet the full phenotypic spectrum remains incompletely characterized, especially in asymptomatic individuals. We conducted a cross‐sectional study including 10 individuals with NS (four with peripheral lymphedema and six without) and 10 age‐ and sex‐matched ...
Inger Norlyk Sheyanth, Benjamin Kelly, Sheyanth Mohanakumar, Steffen Ringgaard, Yoav Dori, Irene Kibæk Nielsen, Uffe Birk Jensen, Vibeke Elisabeth Hjortdal   +7 more
wiley   +1 more source

Prescription patterns of sacubitril/valsartan among patients with hypertension in Japan. [PDF]

Front Cardiovasc Med
Ozaki AF, Nomura H, Terada T, Kato ET, Naqvi AA, Nguyen JT, Kunitsu Y.   +6 more
europepmc   +1 more source

Durability of Blood Pressure Reduction After Renal Denervation in Resistant Hypertension: Mid-Term Real-World Outcomes From Kuwait. [PDF]

J Clin Hypertens (Greenwich)
Alansari YE, Abed BS, Abed BS, Alqouba M, Alsayegh A, Alawadi A, Roomi FA, Mehana M, Almandeel B, Alothman O, Elsanadidy N, Tifooni A, Mula KFAA.   +12 more
europepmc   +1 more source

Antihypertensive Drugs as Potential Repositioning Options for Melanoma: A Map of Pre-Clinical Evidence. [PDF]

Diseases
Mieres NG, Oliveira K, Marques NCB, Azorza NMC, Borba HHL, Pontarolo R, Sari MHM, Bonini JS, Reolon JB, Lazo REL, Ferreira LM.   +10 more
europepmc   +1 more source

Correlation Analysis of Blood Lithium Metabolism Kinetics and Concentration-to-Dose Ratio in Patients With Hypertension and Manic Episodes. [PDF]

Hum Psychopharmacol
Liao D, Li M, Xiong Z, Ji Q, Xia Y, Liu B, Gui X.   +6 more
europepmc   +1 more source

The longevity dividend: Why governments and markets must catch up

Experimental Physiology, EarlyView.
Nikodem Grzesiak, Serena Kern‐Libera, Richard Faragher, Annalisa Jenkins, Guy Coughlan, Damian Miles Bailey, Carina Kern   +6 more
wiley   +1 more source

Description of Antihypertensive Use in Patients With Resistant Hypertension Prescribed Four or More Agents

Hypertension, 2011
Data describing the use of recommended antihypertensive agents in the resistant hypertension population are limited. Treatment recommendations for resistant hypertension include maximizing diuretic therapy by using chlorthalidone and/or adding an ...
Kavita Nair, Joseph Saseen
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Novel antihypertensive agents

Expert Opinion on Investigational Drugs, 2004
Coronary heart disease and cerebrovascular disease continue to be the leading causes of illness and death among adults from developed countries. Their prevalence is strongly related to the effects of many different risk factors, including high blood pressure, cigarette smoking, dyslipidaemia and diabetes.
C, Sierra, Luis M, Ruilope
openaire   +2 more sources

Newer antihypertensive agents

Postgraduate Medicine, 1991
Three recent additions to the list of antihypertensive agents have been approved for use as monotherapy or in combination with other drugs. Betaxolol hydrochloride (Kerlone) maintains its effect for 24 hours, making it a true once-a-day beta blocker. Penbutolol sulfate (Levatol) is as effective as other beta blockers and diuretics.
A M, Rey, K, Grauer, J G, Gums
openaire   +2 more sources